Products & Pipeline
Search Result 1,071
   |
  |
 |
 |
|---|---|---|---|
| Cardiovascular | Von Willebrand factor (vWF) | Phase II | Ablynx NV/SA |
| Cardiovascular | Atherosclerosis | Pre-clinical | AFFiRiS |
| Cardiovascular | Hypertension | Pre-clinical | AFFiRiS |
| Cardiovascular | Generic fondaparinux | Phase II | Alchemia Limited |
| Cardiovascular | Paroxysmal nocturnal hemoglobinuria | Marketed | Alexion Pharma |
| Cardiovascular | Arterial Thrombosis | Phase I | Arena Pharmaceuticals, Inc. |
| Cardiovascular | Pulmonary Arterial Hypertension | Phase I | Arena Pharmaceuticals, Inc. |
| Cardiovascular | Stroke | Pre-clinical | Artielle Immunotherapeutics |
| Cardiovascular | Atherosclerosis | Phase II | BioInvent International AB |
| Cardiovascular | Thrombosis | Phase II | BioInvent International AB |
| Cardiovascular | Acute mycocardial infarction | Phase I | BioLineRx Ltd. |
| Cardiovascular | Hypertension | Phase III | Boryung Pharmaceutical |
| Cardiovascular | Hypertension | Phase II | BTG plc |
| Cardiovascular | Varicose veins | Phase III | BTG plc |
| Cardiovascular | Atrial fibrillation | Marketed | Cardiome |
| Cardiovascular | Congestive heart failure | Phase II | Cephalon |
| Cardiovascular | Aortic valve stenosis | Pre-clinical | Cerenis Therapeutics |
| Cardiovascular | Dyslipidemia with low HDL | Phase I | Cerenis Therapeutics |
| Cardiovascular | Post acute coronary syndrome | Phase II | Cerenis Therapeutics |
| Cardiovascular | Hyperlipidemia | Marketed | Cipher Pharmaceuticals Inc. |
The products introduced in this Products & Pipeline page are intended to provide general information on products in development stage and are subject to change without notice. This information may be updated from time to time but for exact information you
are advised to contact each company directly.
